Candida auris screening, positivity trends, and patient characteristics at the University of Kentucky between 2021 and 2024

Authors

• Faith Fursman, Univ. of Kentucky Medical CenterFollow
• Natalie Fitzsimmons, Univ. of Kentucky Medical Center
• Da Nelle Overton, Univ. of Kentucky Medical Center
• Court Desmond, University of Kentucky College of Medicine
• Kimberly Blanton, Univ. of Kentucky Medical CenterFollow
• Kevin W. Hatton, University of KentuckyFollow
• Rachel Howard, Univ. of Kentucky Medical Center
• David Olafsson, University of Kentucky
• Sean Mctigue, University of Kentucky
• Nicholas Van Sickels, University of Kentucky
• Derek Forster, University of KentuckyFollow
• Takaaki Kobayashi, Univ. of Kentucky Medical Center

Abstract

We evaluated a targeted Candida auris screening program, which revealed a 0.96% positivity rate. The proportion of community-onset cases increased from 8% to 54% following implementation. No significant differences in demographic or clinical characteristics were observed between patients with colonization and those with infection.

Document Type

Article

Publication Date

10-14-2025

Notes/Citation Information

Publisher Copyright: © The Author(s), 2025.

Digital Object Identifier (DOI)

10.1017/ash.2025.10151

Archival?

Archival

Repository Citation

Fursman, Faith; Fitzsimmons, Natalie; Overton, Da Nelle; Desmond, Court; Blanton, Kimberly; Hatton, Kevin W.; Howard, Rachel; Olafsson, David; Mctigue, Sean; Van Sickels, Nicholas; Forster, Derek; and Kobayashi, Takaaki, "Candida auris screening, positivity trends, and patient characteristics at the University of Kentucky between 2021 and 2024" (2025). Surgery Faculty Publications. 70.
https://uknowledge.uky.edu/surgery_facpub/70